- Home
- Equipment
- canada british columbia
- biomarkers
Show results for
Refine by
Biomarkers Equipment Supplied In Canada British Columbia
14 equipment items found
Manufactured by:Response Biomedical Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
D-dimer is a small biomarker of coagulation activation and is present in the blood as a blood clot is degraded. Response Biomedical offers a whole blood quantitative immunoassay D-dimer test, with our proprietary RAMP technology which assess the levels of D-dimer in patients around the world in ~15 minutes. ...
Manufactured by:Response Biomedical Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
Response provides a full range of quantitative tests to aid in the accurate diagnosis of AMI. RAMP cardiovascular tests are designed to be easy to use and provide lab quality results you can count on for emergency situations. Learn more about how our self-calibrating instruments can help improve operational efficiencies in your facility. ...
Manufactured by:Response Biomedical Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
Response Biomedical offers a FDA cleared whole blood immunoassay NT-proBNP test, with our proprietary RAMP technology which detects the levels of N-terminal prohormone of brain natriuretic peptide in patients with congestive heart failure around the world. Read more about how this product will help your physicians and patients where a traditional BNP test ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark has invested in and developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early stage diagnosis of lung ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark’s initial liquid biopsy assay detects SSAT1 using an FDA approved drug. SSAT1 is an enzyme with elevated levels in numerous cancers. The assay targets a well researched and understood metabolic pathway. BioMark of a few unique companies using safe therapeutic agents for diagnostic indication. ...
Manufactured by:Augurex Life Sciences Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
In the development of RA and other inflammatory types of arthritis, multiple factors contribute to disease processes to varying degrees in different patients. 14-3-3η is recognized as a new factor within this process and represents a rationale drug target for personalized medicine alongside its 14-3-3η companion biomarker portfolio described above. Augurex preclinical ...
Manufactured by:Response Biomedical Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
Procalcitonin (PCT) is a biomarker elevated in the blood of patients suffering from sepsis. Physicians use PCT to distinguish bacterial sepsis from other causes of similar symptoms. RAMP Procalcitonin provides quantitative results in ~15 minutes directly from a small blood sample. ...
Manufactured by:StressMarq Biosciences Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
Product Name: c-Met Antibody (pTyr1234). Description: Rabbit Anti-Human c-Met (pTyr1234) Polyclonal. Species Reactivity: Human, Mouse, Rat. Applications: WB. Antibody Dilution: WB (1:250-1:1000); optimal dilutions for assays should be determined by the user. Host Species: Rabbit. Immunogen Species: Human. Immunogen: Synthetic phospho-peptide from human c-Met around the phosphorylation site of ...
Manufactured by:StressMarq Biosciences Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
Product Name: c-Met Antibody (pTyr1349). Description: Rabbit Anti-Human c-Met (pTyr1349) Polyclonal. Species Reactivity: Human, Mouse, Rat. Applications: WB. Antibody Dilution: WB (1:250-1:1000); optimal dilutions for assays should be determined by the user. Host Species: Rabbit. Immunogen Species: Human. Immunogen: Synthetic phospho-peptide from human c-Met around the phosphorylation site of ...
Manufactured by:StressMarq Biosciences Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
Product Name: HER2 Antibody (pTyr877). Description: Rabbit Anti-Human HER2 (pTyr877) Polyclonal. Species Reactivity: Human, Mouse, Rat. Applications: WB, IHC, IP, ELISA. Antibody Dilution: WB (1:250-1:1000); IHC (1:50-1:150); IP (1-2.5 ug per mg lysate); ELISA (1:5000); optimal dilutions for assays should be determined by the user. Host Species: Rabbit. Immunogen Species: Human. Immunogen: ...
Manufactured by:Augurex Life Sciences Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
Citrullination is a highly relevant post-translational modification of proteins that occurs in RA and certain other conditions. In the extracellular space, 14-3-3η becomes citrullinated (cit) in the presence of peptidylarginine deiminases (PAD) enzymes and this extracellular modified form of the protein, cit-14-3-3η, also elicits an auto-immune response that generates cit-14-3-3η ...
Manufactured by:Augurex Life Sciences Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
14-3-3η is not normally present outside of cells. Therefore, in the disease state, the body views it as foreign and mounts an immune response in an attempt to clear it. This immune response generates14-3-3η specific auto-antibodies that are measureable in blood and provide complementary disease information to the 14-3-3η protein. In particular, they are highly specific in very early ...
Manufactured by:RepliCel Life Sciences based inVancouver, BRITISH COLUMBIA (CANADA)
RCS-01 is a proprietary autologous cell therapy being developed to rejuvenate aging or UV-damaged skin.* *This product is currently in clinical testing and not yet commercially available. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells - a type of fibroblast cell - isolated from the hair follicle to repair and regenerate tissue. Though several cell types are ...
Manufactured by:Augurex Life Sciences Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
Extracellular 14-3-3η protein is a potent ligand and activator of intracellular signalling pathways that lead to the up-regulation of inflammation and joint damage factors involved in RA pathogenesis. The 14-3-3η blood test is clinically available as a diagnostic test whereby a positive result indicates a 5 to 50 times greater likelihood of having RA and informs joint damage prognosis and ...